s
i
ANANBIOANAL - 2010
Pharmaceutical R & D Summit
doi:10.4172/2155-9872.1000026
Ocular Pharmacokinetics of Antiviral Nanoformulations by Ultra
High-pressure Liquid Chromatographic Method
Sohail Akhter1
Talegaonkar2
, Gaurav K Jain2
, Roop K Khar2
, Shadab A Pathan1
and Farhan J Ahmad2
, Musarrat H. Warsi1
1Department of Pharmaceutics, Faculty of Pharmacy, Hamdard University, New Delhi, India
2Water India Pvt Ltd, The Corenthum, India
T
he present work describes a rapid and sensitive advance liquid chromatographic
technique, ultra high-pressure liquid chromatography (UHPLC) method with UV
detection to quantify antiviral drug ganciclovir (GCV) in rabbit aqueous humor. After
deproteinisation with acetonitrile, gradient separation of GCV was achieved on a
Waters Acquity BEH C18 (50 mm x 2.1 mm, 1.7 µm) column at 50°C. The mobile
phase consisted of 0.1% trifluoroacetic acid in water (pH 3.5) and acetonitrile (95:5,
v/v) at a flow rate of 0.45 mL/min. GCV analysis was performed at a wavelength of
254 nm with total run time of 3 min. Method was found to be selective, linear (r2
0.999), accurate (recovery, 97.0–100.2%) and precise (CV, ≤ 3.1%) in the selected
concentration range of 0.1–1.0 µg/mL. Detection and quantitation limit of GCV in
aqueous humor were 3.0 and 10.0 ng/mL, respectively. The method was applied
to compare aqueous humor levels of GCV after single topical instillation of GCV
solution, GCV nanoparticles, GCV nanocomplexes and GCV niosomal dispersions.
Topical instillation of GCV-NCs (AUC0→t
(AUC0→t
mL) and nearly 2.5 fold higher than the GCV-NPs (AUC0→t
The results indicate that the nanocomplexes and niosomal dispersions increases
ocular bioavailability of GCV and prolong its residence time in the eye.
, Prakash Chander2
, Sushma
=
, 3380.5±29.3 ng.hr/mL) provided approximately 5 fold increase in the
relative ocular bioavailability compared with GCV solution (AUC0→t
, 3440.7±26.2 ng.hr/mL) and GCV-NDs
, 650.8±14.9 ng.h/
, 1350.2±18.5 ng.h/mL).
ANALBIOANAL-2010
O
M
I
C
S
P
i
u
h
b
l
n
g
G
r
o
u
p